Therapy News and Research

RSS
Study: Black and white men with prostate cancer prioritize treatment-related factors differently

Study: Black and white men with prostate cancer prioritize treatment-related factors differently

Adding a second HER2-targeted treatment may improve outcomes for some women with breast cancer

Adding a second HER2-targeted treatment may improve outcomes for some women with breast cancer

Study: 1 in 6 patients on new blood-thinning medications may not be receiving recommended dose

Study: 1 in 6 patients on new blood-thinning medications may not be receiving recommended dose

Older people with persistent pain more likely to develop dementia

Older people with persistent pain more likely to develop dementia

Findings point to potential new treatment for people with newly diagnosed EGFR-positive NSCLC

Findings point to potential new treatment for people with newly diagnosed EGFR-positive NSCLC

FDA approves expanded use of Sapien 3 THV as valve-in-valve treatment for high-risk patients

FDA approves expanded use of Sapien 3 THV as valve-in-valve treatment for high-risk patients

Study explores effects of androgen deprivation therapy on overall geriatric health

Study explores effects of androgen deprivation therapy on overall geriatric health

Study reveals positive experience and attitude of patients on electroconvulsive therapy

Study reveals positive experience and attitude of patients on electroconvulsive therapy

Study shows effectiveness of 3 months of chemotherapy in colon cancer patients after surgery

Study shows effectiveness of 3 months of chemotherapy in colon cancer patients after surgery

New genomic sequencing approach could be first step toward blood tests for early cancer detection

New genomic sequencing approach could be first step toward blood tests for early cancer detection

Single-dose radiotherapy effectively reduces spinal cord compression symptoms

Single-dose radiotherapy effectively reduces spinal cord compression symptoms

Testicular cancer survivors with low testosterone more likely to have chronic health problems

Testicular cancer survivors with low testosterone more likely to have chronic health problems

Psychological intervention reduces fear of recurrence in breast cancer survivors

Psychological intervention reduces fear of recurrence in breast cancer survivors

Novartis to collaborate with IBM Watson Health for improving outcomes in advanced breast cancer

Novartis to collaborate with IBM Watson Health for improving outcomes in advanced breast cancer

EFMT technology results in greater reduction of major depressive disorder symptoms

EFMT technology results in greater reduction of major depressive disorder symptoms

New breakthrough offers hope for allergy sufferers

New breakthrough offers hope for allergy sufferers

Seven-hour sleep duration increases chances of achieving remission in depressed patients with insomnia

Seven-hour sleep duration increases chances of achieving remission in depressed patients with insomnia

Online intervention can relieve distress, improve quality of life for cancer patients

Online intervention can relieve distress, improve quality of life for cancer patients

Study finds steady decline in severe health problems for childhood cancer survivors

Study finds steady decline in severe health problems for childhood cancer survivors

Brief psychological intervention reduces depressive symptoms in patients with advanced cancer

Brief psychological intervention reduces depressive symptoms in patients with advanced cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.